Understanding effect site pharmacology of uprifosbuvir, a hepatitis C virus nucleoside inhibitor

Therapeutic area :

Berg van der P, Gao W, Ahsman M.J, Arrington L, Kesisoglou F, Miller R, Post T.M, Rizk M.L. Understanding effect site pharmacology of uprifosbuvir, a hepatitis C virus nucleoside inhibitor: Case study of a multidisciplinary modeling approach in drug development. CPT Pharmacometrics Syst Pharmacol. 2021 May 2. doi: 10.1002/psp4.12644. Epub ahead of print. PMID: 33934558. . [Link to publication]